Interferon adjunct reduces MS lesions

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Interferon adjunct reduces MS lesions

Postby MSUK » Sun Jun 06, 2010 3:55 pm

Image

The oral drug teriflunomide demonstrates short-term safety and reduces lesions in multiple sclerosis for up to one year when used in combination with interferon beta, according to a study presented here.

Treatment-emergent adverse events were similar to placebo for patients on combination therapy, and the relative risk reduction for gadolinium-enhancing lesions on active treatment was more than 80% at 1 year, compared to patients on interferon beta alone.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/2933
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2089
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users